<?xml version="1.0" encoding="UTF-8"?>



<records>

  <record>
    <language>eng</language>
          <publisher>Oriental Scientific Publishing Company</publisher>
        <journalTitle>Biosciences Biotechnology Research Asia</journalTitle>
          <issn>0973-1245</issn>
            <publicationDate>2016-06-20</publicationDate>
    
        <volume>12</volume>
        <issue>Spl.Edn.2</issue>

 
    <startPage>181</startPage>
    <endPage>187</endPage>

	 
      <doi>10.13005/bbra/2188</doi>
        <publisherRecordId>12867</publisherRecordId>
    <documentType>article</documentType>
    <title language="eng">In Silico Approach for Designing Potent Inhibitors against Tyrosinase</title>

    <authors>
	 


      <author>
       <name>Azizeh Asadzadeh</name>

 
		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name>Afshin Fassihi</name>


		
	<affiliationId>2</affiliationId>

      </author>
    

	 


      <author>
       <name>Parichehreh Yaghmaei</name>

		
	<affiliationId>1</affiliationId>
      </author>
    

	 


      <author>
       <name>Morteza Pourfarzam</name>

		
	<affiliationId>3</affiliationId>
      </author>
    


	


	
    </authors>
    
	    <affiliationsList>
	    
		
		<affiliationName affiliationId="1">Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran.</affiliationName>
    

		
		<affiliationName affiliationId="2">Department of Medicinal Chemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliationName>
    
		
		<affiliationName affiliationId="3">Department of Biochemistry, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.</affiliationName>
    
		
		
		
	  </affiliationsList>






    <abstract language="eng">In recent years regulation of the enzymatic activity of tyrosinase has been the
main focus of investigation due to its potential applications in medicine, agriculture and
cosmetics. In the present study, Eighteen derivatives of 3-hydroxypyridine-4-one scaffold
were subjected to molecular docking studies to investigating the mode of interaction of
the compounds with tyrosinase active site. We applied Autodock tools 4.2, in order to set
up the docking runs and predict the inhibitors binding free energy. The final product of
molecular docking was clustered to specify the binding free energy and optimal docking
energy conformation that is investigated as the best docked structure. Among the total of
molecules tested, it was proved that Ligands 3, and 10 have the lowest binding free energy.
The docked conformation revealed that these compounds could form metal-ligand
interaction with The Cu2+ ions in the active site. These insilico results can thus serve as
a template for further studies invitro and invivo.</abstract>

    <fullTextUrl format="html">https://www.biotech-asia.org/vol12_nospl_edn2/in-silico-approach-for-designing-potent-inhibitors-against-tyrosinase/</fullTextUrl>



      <keywords language="eng">
        <keyword>In Silico Approach; Docking; Kojic acid; Tyrosinase</keyword>
      </keywords>

  </record>
</records>